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amino acid residues of an enzyme and its ligands
(substrate and transition state analogs, cofactors,
inhibitors and products). It is available online at
http://precise.bu.edu/.Inthecurrentversion,allinfor-
mation on interactions is extracted from the enzyme–
ligand complexes in the Protein Data Bank (PDB) by
performing the following steps: (i) clustering homo-
logous enzyme chains such that, in each cluster, the
proteinshavethesameECnumberandallsequences
are similar; (ii) selecting a representative chain for
each cluster; (iii) selecting ligand types; (iv) finding
non-bonded interactions and hydrogen bonds; and
(v) summing the interactions for all chains within
the cluster. The output of the search is the color-
coded sequence of the representative. The colors
indicate the total number of interactions found at
each amino acid position in all chains of the cluster.
Clicking on a residue displays a detailed list of inter-
actionsforthatresidue.Optionalfiltersallowrestrict-
ing the output to selected chains in the cluster, to
non-bonded or hydrogen bonding interactions, and
to selected ligand types. The binding site information
is essential for understanding and altering substrate
specificity and for the design of enzyme inhibitors.
INTRODUCTION
One of the most important functions of proteins is serving as
enzymes in catalyzing biochemical reactions. Enzyme nomen-
clature (1) is available through the Nomenclature Committee
of the International Union of Biochemistry and Molecular
Biology (NC-IUBMB) Enzyme List (2) and the ENZYME
database (3). Information on the functions of enzymes is pro-
vided by BRENDA(4), which contains an extensive collection
of facts related to enzymes, including reaction speciﬁcity,
functional parameters, substrates, products and inhibitors.
IntEnz (5) is a relational database integrating enzyme data
from all three of these sources.
The current explosion of structural data has emphasized the
need to relate enzyme structures to functions (6). Databases
addressing this need are PROCAT (7) and the more recent
CSA (8) that provides catalytic residue annotation. How-
ever, catalytic sites generally only consist of a few, highly
conserved amino acid residues, whereas there are usually
10–20 amino acid positions in an enzyme that directly interact
with various ligands, including substrates, products, cofactors
and inhibitors. No resource has been developed that permits
the systematic study of all residues involved in ligand binding,
although the substrate speciﬁcity of an enzyme is determined
by these rather than only by the catalytic residues. The best
tool to obtain information on speciﬁc enzyme–ligand interac-
tions is the Sequence Annotated by Structure (SAS) facility of
the PDBsum website (9). SAS and PDBsum use the programs
HBPLUS (10), to generate lists of hydrogen bonds and non-
bonded contacts from the three dimensional (3D) coordinates
in a PDB ﬁle, and the LIGPLOT program to display the inter-
actions (11). The shortcoming is that each enzyme–ligand
complex should be analyzed separately, and then the results
be collected to form a summary which provides the consensus
characterization of the binding site in a homologous family
of enzymes.
Given a query enzyme, the main function of PRECISE is to
ﬁnd all relevant structure ﬁles in the PDB (12), align the
corresponding sequences, extract all enzyme–ligand interac-
tions and construct the consensus binding site, i.e. identify all
residue positions that contribute to ligand binding in any of the
structures, ranked on the basis of the frequency of such inter-
actions found for the residues at each position. Future releases
of the database will also include interactions predicted
by solvent mapping, a novel method for determining protein
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doi:10.1093/nar/gki091binding sites based on their structure (13). While this explains
the origin of ‘PRE’ in the name of PRECISE, the current
version is based exclusively on interactions extracted from
the PDB structure ﬁles.
BINDING SITES VERSUS CATALYTIC SITES IN
ENZYMES
As mentioned above, the broadly deﬁned binding or interac-
tion site of an enzyme means the collection of all amino acid
residues that interact with any ligand related to enzyme func-
tion, including substrates, products, cofactors and inhibitors.
The expressions of ‘functional site’ and ‘recognition site’ are
also used in the literature. The binding or interaction site
generally includes 10–20 amino acid residues, and should
be distinguished from the strict catalytic site that is responsible
for the enzyme action and generally comprises only three or
four residues. We recall that the PROCAT and CSA databases
(7,8) provide catalytic residue annotation. These residues
obviously interact with the substrate, and hence are part of
the binding site. Since the catalytic mechanism cannot be
determined from the structures of complexes alone (although
co-crystallized transition state analogs provide useful informa-
tion), in PRECISE we do not attempt to distinguish the cat-
alytic residues from the rest of the binding site.
ENZYME CLUSTERS WITH HIGH SEQUENCE
SIMILARITY
The basis of enzyme classiﬁcation is the assignment of a
speciﬁc numerical identiﬁer, the Enzyme Classiﬁcation
(EC) number, which identiﬁes the enzyme in terms of its
function. The ﬁrst digit represents the type of reaction cata-
lyzed. The second digit of the EC number refers to the sub-
class, which generally contains information about the type of
compound or group involved.The third digit, the sub-subclass,
further speciﬁes the nature of the reaction and the fourth digit
isaserial numberthatisusedtoidentifythe individual enzyme
withina sub-subclass.Enzymeswith thesameECnumber,e.g.
lysozyme (EC 3.2.1.17) have the same catalytic function, but
may include several families (e.g., hen egg-white lysozyme
andT4lysozyme)thatsigniﬁcantlydifferbothinsequence and
structure.Collectingconsensusinformation,wegroupenzymes
that have the same EC number and also have very high
sequence similarity. Such highly homologous proteins share
the same tertiary fold, but can still have localized differences in
their binding sites and hence in substrate speciﬁcity. However,
since the sequences can be reliably aligned, we can assess the
role of each amino acid position in forming the binding site.
An important step in the construction of PRECISE is the
clustering of enzymes such that members of each cluster have
the sameECnumberandhave highsequencesimilarity toeach
other. To assure the second property, we have considered the
clusters in the Non-Redundant PDB Chain Set (http://
www.ncbi.nlm.nih.gov/Structure/VAST/nrpdb.html), also
known as the nrPDB database, maintained by the NCBI.
The clusters in nrPDB have been constructed by comparing
all chains available from PDB (12) with each other using the
BLAST algorithm (14). The chains are then clustered into
groups of sequence-similar entries using a single-linkage
clustering procedure. Chains within a sequence-similar
group thus derived are also ranked according to the precision
and completeness of their structural data. The following mea-
sures of the structural quality are used in this order of priority:
(i) lower percentage of residues with unknown amino acid
type; (ii) lower percentage of residues with incomplete coor-
dinate data; (iii) lower percentage of residues whose coordi-
nate data are missing; (iv) lower percentage of residues with
incomplete side-chain coordinate data; (v) higher resolution;
(vi) larger number of chains (subunits) contained in the PDB
entry; (vii) larger number of heterogens contained in the PDB
entry; (viii)larger number ofdifferent typesof heterogens;(ix)
larger number of residues; and (x) alphanumerical order of
their PDB codes.
To form the clusters in PRECISE we consider the enzymes
belonging to the same EC number, and group them into clus-
ters of sequence-similar elements that are members of the
same nrPDB cluster obtained using the BLAST P-value of
10
40. The top-ranked chain is generally chosen as the repre-
sentative of the group. In some cases, however, a lower-ranked
chain was chosen. For example, if the top-ranked chain was a
mutant protein and there was a native protein with reasonably
comparable structural quality, then that lower-ranked native
protein might replace the mutant as the representative. Repre-
sentatives from all of the groups together form a non-redun-
dant set of enzymes with different binding sites. The
motivation for introducing representatives is 2-fold. First,
the interaction frequencies at each amino acid position are
projected onto the representative sequence. Second, we will
apply computational solvent mapping onto representatives of
clusters with no enzyme–ligand complexes available in order
to predict putative interaction. While the current version of
PRECISE does not include predicted interactions, the avail-
ability of consensus interaction sites for a large fraction of
enzymes is very useful in a variety of applications.
PRECISE version 1.0 is based on the August 31, 2004
version of the nrPDB (12) and the September 17, 2004 version
ofEC-to-PDB databases,the latter containing 12532 ﬁles. The
total number of enzyme chains in these ﬁles is 23872, belong-
ing to 1176 unique EC numbers. Thus, in the PDB the average
number of enzyme chains per EC number is 20.29. How-
ever, the distribution is very uneven, i.e. the majority of EC
numbers is represented with less than 10 chains, whereas a
few have very many members (Figure 1a). Clustering chains
with the same EC number and pairwise BLAST P-value of
10
40 or less yields 2280 clusters, i.e. on average, 1.93 clusters
per enzyme number, with 10.47 chains in each cluster.
Figure 1b and c show the distributions for the number of
clusters per EC number, and for the number of enzyme chains
per cluster, respectively. According to Figure 1b, 779 EC
numbers have only chains belonging to a single cluster.
More generally, over 90% of EC numbers include only ﬁve
or fewer clusters of chains that are not homologous to each
other. It is interesting to note that the frequencies of EC
numbers with even number of chains are always somewhat
higher than the frequencies of EC numbers with similar but
odd number of chains (Figure 1a). The same observation
applies to the distributions of clusters with even and odd
number of chains (Figure 1c). While the ﬁrst appears to be
strange, the rule becomes easy to understand when we
take into account that many enzymes form homodimers and
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and clusters with even number of chains.
Since the selected P-value of 10
40 implies high-sequence
identity and similarity within clusters (see Figure 1d), the
alignment of sequences within each cluster is very simple.
A semi-global dynamic programming algorithm with the
GONNET matrix (15), gap penalty of 8, and extension penalty
of0.25wasusedtoaligneachsequencetotherepresentativeof
the cluster. The pairwise alignments within a cluster are
stacked upon each other to generate a multiple sequence align-
ment of all sequences relative to the representative sequence.
Because the only concern is that interactions to a residue
position in a member of the cluster are related to the correct
residue position of the representative, there is no need for a
more sophisticated multiple sequence alignment that best
aligns every cluster member to each other.
EXTRACTING THE INTERACTIONS
For each chain, the interactions between the protein and the
ligand were extracted using the HBPLUS program with the
default parameter values to deﬁne non-bonded and hydrogen
bond interactions. The attributes stored for each interactions
are the PDB code and chain identiﬁer of the protein; the name,
heteroatom code and type of the ligand; the interacting residue
and atom in the protein, the interacting atom in the ligand and
the type of the interaction (non-bonded or hydrogen bond).
The ligand types we distinguish are peptide, nucleotide, cofac-
tor, metal ion, other inorganic ion and ‘other’, the latter repre-
senting the molecules in none of the above categories. The
number of interactions for each residue in each chain was
obtained by summing the interactions in which the atoms
belonging to that residue participate, without any upper
bound on the number of interactions. The number of interac-
tions at a particular amino acid position of the aligned
sequences was calculated by summing the interactions
found at that position for all members of the cluster.
PRECISE currently contains a total of 5435107 atom–atom
interactions that are distributed among 1533 clusters, i.e. 747
of the 2280 clusters do not have any interactions. The numbers
of clusters with different ligand types are as follows: peptides
262, nucleotides 67, cofactors 554, metal ions 733, inorganic
ions 673 and ‘others’ 1061. Figure 2 shows the distributions
of the percentages of residues with a given number of
Figure 1. Statistics for enzyme structures in the PDB. (a) Distribution of the 23872 enzyme chains in the PDB among the 1176 different EC numbers. The graph is
truncated at 70 enzyme chains per EC number; there are isolated instances of higher values up to 933 enzyme chains per EC number. (b) Distribution of the 2280
sequence-similarenzymeclustersamongthe1176ECnumbers.Thegraphistruncatedat10clustersperECnumber;thereareisolatedinstancesofhighervaluesupto
44 clustersperECnumber.(c) Distributionofthe 23872 enzymechainsinthe PDBamongthe2280sequence-similar clusters.Thegraphis truncatedat 40enzyme
chains per cluster; there are isolated instances of higher values up to 475 enzyme chains per cluster. (d) Distribution of clusters with given levels of amino acid
sequence identity.
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peak at 1–2% of the residues containing 20–30 interactions.
This conﬁrms that the information contained in our database is
speciﬁc enough, i.e. the ligands interact with a relatively small
fraction of the residues rather than having interactions broadly
distributed over long stretches of the sequence.
THE PRECISE WEBSERVER
PRECISE is implemented as a relational database using MS
SQL Server 2000 as the backend. The database structure can
be classiﬁed into three sections, Enzyme Information, Cluster
Information and Interaction Information. The three sections
are related but are independent enough to allow for the update
of one without affecting the others. The PRECISE website is
hosted on MS IIS 6.0. The web interface is implemented using
a combination of ASP.NET and JavaScript. ASP.NET is used
for the computationally intensive functions of the site and to
provide the database connectivity layer, in the form of ADO.
NET. JavaScript is used throughout the site to enhance the
usability and responsiveness within a web browser.
The online version of PRECISE is available at http://
precise.bu.edu/. Queries can be made using PDB code or
EC number. An incomplete EC number will display all
clusters that are compatible with the query. If there are non-
homologous chains present in structure for the query PDB
code, a subsequent page will let users select any of the chains.
The main output page (Figure 3a) shows the color-coded
sequence of the representative of the cluster. The blue to
red color-scheme indicates the residues that belong to the
binding site, as well as the total number of interactions
found at each amino acid position in all chains of the cluster.
This is the most important information provided by the page.
Clicking on any ‘colored’ residue (i.e. on a residue that has at
least one interaction) displays a separate panel with a detailed
listofinteractionsfortheselectedresidue(Figure3b).Foreach
interaction, the list shows the PDB code and chain identiﬁer of
the protein; the name, heteroatom code and type of the ligand;
the interacting residue and atom in the protein, and the type
of the interaction(non-bondedor hydrogen bonds). Itisimpor-
tant that the list shows both the ‘interaction position’, i.e. the
originalsequencenumberof the interactingresidue inthe PDB
ﬁle, and the ‘aligned position’, which is the sequence number
of the same residue in the alignment of sequences for the entire
cluster. A button is provided to open a new window with the
alignment. On the right-hand side of the sequence in the main
output page, separate panels show all the PDB codes and chain
identiﬁers of the entries that form the cluster. The user may
select any subset of these entries and recalculate the list of
interactions. Additional panels permit the users to restrict the
set of interactions to selected interaction types (i.e. non-
bonded or hydrogen bond) and to selected ligand types (i.e.
peptides, nucleotides, cofactors, metal ions, other inorganic
ions or ‘others’). Again, any subset of these can be selected to
produce the list of interactions.
CURRENT WORK AND FUTURE DEVELOPMENT
(i) We are in the process of investigating the origin of
some irregularities. In particular, our alignment yields
low sequence identity for a limited number of clusters
Figure 2. Distribution of the 23872 enzyme chains among categories defined as having a given percentage of the residues with certain number of interactions,
showingthat,inmostenzymes,1–2%oftheresidueshave20–30interactionswhichformthepeakofthetwo-dimensionaldistributionwithvariablesrepresentingthe
percentage of residues and the number of interactions per residue.
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potential problems. The alignment in these clusters is
being inspected manually.
(ii) As we describe, the 1176 EC numbers in the PDB are
subdivided into 2280 sequence-similar clusters. We are in
the process of separately annotating these clusters, i.e.
identifying the reasons why the same enzymatic action
is achieved by non-homologous proteins. The analysis
includes the comparison of binding site structures of en-
zymes that have the same EC number but are in different
clusters, and will involve merging some of the clusters.
(iii) We will provide a rotatable 3D representation of the bind-
ing site in any chain using the Java-based Jmol molecular
viewer. The atom set selected for display will include all
atoms of the ligand(s), and the side chains of all amino
acids that are part of the consensus binding site for the
given cluster, including the ones that may not interact
with the ligand in the particular chain.
(iv) At this point, updating PRECISE to account for new
structures in the PDB requires rerunning all our scripts
that have been used to generate the database. We will
develop scripts that align new PDB entries with the ex-
isting representatives and either add them to an existing
cluster or create a new cluster, thereby facilitating regular




right shows all the PDB codes and chain identifiers of the entries that form the cluster. The user may select any subset of these entries and recalculate the list of
interactions. The two additional panels permit the users to restrict the set of interactions to selected interaction types (i.e. non-bonded or hydrogen bond) and to
selected ligand types (i.e. peptides, nucleotides, cofactors, metal ions, other inorganic ions or ‘others’). Any subset of these can be selected to produce the list of
interactions.Clickingonany‘colored’residuedisplaysthepanelshownin(b).(b)Partofthedetailedlistofinteractionsforaresiduein2TLX.Foreachinteraction,
the list shows the PDB code and chain identifier of the protein; the name, heteroatom code, and type of the ligand; the interacting residue and atom in the protein,
and the type of the interaction (non-bonded or hydrogen bond). The list shows both the ‘interaction position’, i.e. the original sequence number of the interacting
residue in the PDB file, and the ‘aligned position’, which is the sequence number of the same residue in the alignment of sequences for the entire cluster.
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interactions predicted by computational solvent mapping.
The latter is a powerful tool for the identification and
characterization of binding sites of enzymes (13,16,17).
The method moves molecular probes—small organic mo-
lecules containing various functional groups—around the
protein surface, finds favorable positions using empirical
free energy functions, clusters the conformations and
ranks the clusters on the basis of the average free energy.
The mapping procedure reproduces the available experi-
mentalsolventmappingresults(18–22).Averyimportant
result is that using at least six different solvents as probes,
the consensus sites found by the mapping are always in
major subsites of the enzyme binding site, and as a result,
the amino acid residues that interact with the probes also
bind the specific ligands of the enzyme (13). Thus, the
method provides detailed and reliable information on the
important aminoacidresiduesinthebindingsite(13).We
have already mapped the surface of over 50 enzymes for
binding sites. Such predicted interactions will be consid-
ered as a separate category in PRECISE. This will permit
the comparison of predicted and observed interactions
sites if the latter can be determined from the available
X-ray structures of complexes. The PRECISE webpage
will also contain an email server, and thus users will be
able to request the mapping of a specific enzyme by
sending an email to the website. Since the mapping runs
will be started manually, the response time will be about
twodays. Oncethe mapping isfinished,the resultswill be
added to the PRECISE database,and an email will be sent
to the user.
DISCUSSION
PRECISE provides a summary of interactions between the
amino acid residues of an enzyme and its various ligands
(substrate and transition state analogs, cofactors, inhibitors
and products), thereby complementing other databases that
contain enormous wealth of data on enzymes, but do not
provide information on the binding site. BRENDA (4) cur-
rently has information on 3600 different EC numbers,
including nomenclature, isolation and preparation, stability,
reaction speciﬁcity, functional parameters and references. In
particular, BRENDA lists the different ligands (substrates,
products, inhibitors, cofactors and metals/ions) but without
any type of data on the interactions between these ligands
and the protein. The Catalytic Site Atlas (CSA) (8) provides
catalytic residue annotation for enzymes in the PDB. Unlike
the catalytic residues that are highly conserved, residues
that participate in ligand binding but do not directly con-
tribute to the catalytic activity can change through evolu-
tion, and are responsible for changes in substrate speciﬁcity.
Thus, information on the entire ligand binding site is
required for understanding the energetic contributions to
substrate binding, for developing modiﬁed enzymes using
methods of protein engineering or directed evolution, and
for the design of enzyme inhibitors. Once residues of
the binding site are identiﬁed and their importance is
determined using PRECISE, the subset of catalytic residues
can be found by CSA.
ACKNOWLEDGEMENTS
We thank Jahnavi Prasad for help with the alignment. This
research has been supported by grants DBI-9904834 from
the National Science Foundation, GM64700 from the
National Institute of Health and P42 ES07381 from the
National Institute of Environmental Health Sciences.
REFERENCES
1. Tipton,K.F. and Boyce,S. (2000) Enzyme classification and
nomenclature. In Nature Encyclopedia of Life Sciences. Nature
Publishing Group, London.
2. IUBMB (1992) Enzyme Nomenclature: Recommendations (1992) of the
NomenclatureCommitteeoftheInternationalUnionofBiochemistryand
Molecular Biology. Academic Press, San Diego, CA.
3. Bairoch,A. (2000) The ENZYME database in 2000. Nucleic Acids Res.,
28, 304–305.
4. Schomburg,I., Chang,A. and Schomburg,D. (2002) BRENDA, enzyme
data and metabolic information. Nucleic Acids Res., 30, 47–49.
5. Fleischmann,A., Darsow,M., Degtyarenko,K., Fleischmann,W.,
Boyce,S., Axelsen,K.B., Bairoch,A., Schomburg,D., Tipton,K.F. and
Apweiler,R. (2004) IntEnz, the integrated relational enzyme database.
Nucleic Acids Res., 32, 434–437.
6. Erlandsen,H.,Abola,E.E.andStevens,R.C.(2000)Combiningstructural
genomicsandenzymology:completingthepictureinmetabolicpathways
and enzyme active sites. Curr. Opin. Struct. Biol., 10, 719–730.
7. Wallace,A.C., Laskowski,R.A. and Thornton,J.M. (1996) Derivation of
3Dcoordinatetemplatesforsearchingstructuraldatabases:applicationto
the Ser-His-Asp catalytic triads of the serine proteinases and lipases.
Protein Sci., 5, 1001–1013.
8. Porter,C.T., Bartlett,G.K.J. and Thornton,J.M. (2004) The Catalytic Site
Atlas: a resource of catalytic sites and residues identified in enzymes
using structural data. Nucleic Acids Res., 32, 129–133.
9. Laskowski,R.A. (2001) PDBsum: summaries and analyses of PDB
structures. Nucleic Acids Res., 29, 221–222.
10. McDonald,I.K. and Thornton,J.M. (1994) Satisfying hydrogen bonding
potential in proteins. J. Mol. Biol., 238, 777–793.
11. Wallace,A.C., Laskowski,R.A. and Thornton,J.M. (1995). LIGPLOT: a
program to generate schematic diagrams of protein–ligand interactions.
Protein Eng., 8, 127–134.
12. Westbrook,J., Feng,Z., Jain,S., Bhat,T.N, Thanki,N., Ravichandran,V.,
Gilliland,G.L., Bluhm,W., Weissig,H., Greer,D.S., Bourne,P.E. and
Berman,H.M. (2002) The Protein Data Bank: unifying the archive.
Nucleic Acids Res., 30, 245–248.
13. Silberstein,M., Dennis,S., Brown,L., Kortvelyesi,T., Clodfelter,K. and
Vajda,S. (2003) Identification of substrate binding sites in enzymes by
computational solvent mapping. J. Mol. Biol., 332, 1095–1113.
14. Altschul,S.F., Gish,W., Miller,W., Myers,E.W. and Lipman,D.J. (1990)
Basic local alignment search tool. J. Mol. Biol., 215, 403–410.
15. Gonnet,G.H.,Cohen,M.A.andBenner,S.A.(1992)Exhaustivematching
of the entire protein sequence database. Science, 256, 1443–1445.
16. Dennis,S., Kortvelyesi,T. and Vajda,S. (2003) Computational mapping
identifies the binding sites of organic solvents on proteins. Proc. Natl
Acad. Sci. USA, 99, 4290–4295.
17. Kortvelyesi,T., Dennis,S., Silberstein,M., Brown,L.,III and Vajda,S.
(2003) Algorithms for computational solvent mapping of proteins.
Proteins, 51, 340–351.
18. Mattos,C.andRinge,D.(1996)Locatingandcharacterizingbindingsites
on proteins. Nat. Biotechnol., 14, 595–599.
19. Ringe,D. and Mattos,C. (1999) Analysis of the binding surfaces of
proteins. Med. Res. Rev., 19, 321–331.
20. Allen,K.N., Bellamacina,C.R., Ding,X., Jeffery,C.J., Mattos,C.,
Petsko,G.A.and Ringe,D. (1996) An experimental approach to mapping
the binding surfaces of crystalline proteins. J. Phys. Chem., 100,
2605–2611.
21. English,A.C., Done,S.H., Caves,L.S., Groom,C.R. and Hubbard,R.E.
(1999) Locating interaction sites on proteins: the crystal structure of
thermolysin soaked in 2% to 100% isopropanol. Proteins, 37, 628–640.
22. English,A.C., Groom,C.R. and Hubbard,R.E. (2001) Experimental and
computational mapping of the binding surface of a crystalline protein.
Protein Eng., 14, 47–59.
Nucleic Acids Research, 2005, Vol. 33, Database issue D211